Literature DB >> 17597476

Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.

Christine E McLaren1, James C Barton, Victor R Gordeuk, Lu Wu, Paul C Adams, David M Reboussin, Mark Speechley, Henry Chang, Ronald T Acton, Emily L Harris, Andrea M Ruggiero, Oswaldo Castro.   

Abstract

Elevated mean corpuscular volume (MCV) is common in persons with hemochromatosis associated with HFE C282Y homozygosity. We evaluated data from the subset of non-Hispanic white participants in the Hemochromatosis and Iron Overload Screening Study to determine if elevated MCV in C282Y homozygotes is related to this genotype or to serum iron measures. Regression analysis was used to model MCV and Hb from transferrin saturation (TfSat), serum ferritin (SF), mean corpuscular hemoglobin concentration, red blood cell count, age, HFE genotype, Field Center, and presence of liver-related abnormalities in C282Y homozygotes and control subjects without HFE mutations (wt/wt genotype). Mean MCV was higher in C282Y homozygotes than in HFE wt/wt controls (94.4 vs. 89.7 fL in women; 95.3 vs. 91.2 fL in men; P < 0.0001 for both). These differences were largely associated with increased mean TfSat and SF in C282Y homozygotes. Adjusted mean MCV was 92.0 fL (95% confidence interval, 91.1, 92.9) in female C282Y homozygotes and 90.9 fL (90.3, 91.5) in controls. Among women with SF in the reference range 20-200 microg/L, adjusted mean MCV was 92.9 fL, (91.7, 94.2) in C282Y homozygotes, 1.8 fL higher than in controls (P = 0.013). The adjusted mean MCV of male C282Y homozygotes and controls was similar (P = 0.30). Adjusted mean Hb was 0.2 g/dL higher in women with C282Y/C282Y than in controls. Greater mean MCV in C282Y homozygosity reflects increased mean TfSat and mean SF in men and women; an additional effect of genotype on MCV and Hb was detected in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597476     DOI: 10.1002/ajh.20937

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  12 in total

1.  Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis.

Authors:  Pedro Ramos; Ella Guy; Nan Chen; Catia C Proenca; Sara Gardenghi; Carla Casu; Antonia Follenzi; Nico Van Rooijen; Robert W Grady; Maria de Sousa; Stefano Rivella
Journal:  Blood       Date:  2010-11-08       Impact factor: 22.113

Review 2.  Iron metabolism: interactions with normal and disordered erythropoiesis.

Authors:  Tomas Ganz; Elizabeta Nemeth
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

3.  Cytokine and Gene Expression Profiling in Patients with HFE-Associated Hereditary Hemochromatosis according to Genetic Profile.

Authors:  Heidi Kristine Grønlien; Trine Eker Christoffersen; Camilla Furlund Nystrand; Lamya Garabet; Terje Syvertsen; Morten K Moe; Ole Kristoffer Olstad; Christine Monceyron Jonassen
Journal:  Acta Haematol       Date:  2020-12-16       Impact factor: 2.195

4.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

5.  Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.

Authors:  Victor R Gordeuk; David M Reboussin; Christine E McLaren; James C Barton; Ronald T Acton; Gordon D McLaren; Emily L Harris; Jacob A Reiss; Paul C Adams; Mark Speechley; Pradyumna D Phatak; Phyliss Sholinsky; John H Eckfeldt; Wen-Pin Chen; Leah Passmore; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-08       Impact factor: 10.047

6.  Therapeutic Depletion of Iron Stores Is Not Associated with a Reduced Hemoglobin Mass in a Hemochromatosis Patient.

Authors:  Nina Wrobel; Torben Pottgiesser; Philipp Birkner; Peter Deibert; Christoph Ahlgrim
Journal:  Case Rep Gastroenterol       Date:  2016-08-31

7.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.

Authors:  Santhi K Ganesh; Neil A Zakai; Frank J A van Rooij; Nicole Soranzo; Albert V Smith; Michael A Nalls; Ming-Huei Chen; Anna Kottgen; Nicole L Glazer; Abbas Dehghan; Brigitte Kuhnel; Thor Aspelund; Qiong Yang; Toshiko Tanaka; Andrew Jaffe; Joshua C M Bis; Germaine C Verwoert; Alexander Teumer; Caroline S Fox; Jack M Guralnik; Georg B Ehret; Kenneth Rice; Janine F Felix; Augusto Rendon; Gudny Eiriksdottir; Daniel Levy; Kushang V Patel; Eric Boerwinkle; Jerome I Rotter; Albert Hofman; Jennifer G Sambrook; Dena G Hernandez; Gang Zheng; Stefania Bandinelli; Andrew B Singleton; Josef Coresh; Thomas Lumley; André G Uitterlinden; Janine M Vangils; Lenore J Launer; L Adrienne Cupples; Ben A Oostra; Jaap-Jan Zwaginga; Willem H Ouwehand; Swee-Lay Thein; Christa Meisinger; Panos Deloukas; Matthias Nauck; Tim D Spector; Christian Gieger; Vilmundur Gudnason; Cornelia M van Duijn; Bruce M Psaty; Luigi Ferrucci; Aravinda Chakravarti; Andreas Greinacher; Christopher J O'Donnell; Jacqueline C M Witteman; Susan Furth; Mary Cushman; Tamara B Harris; Jing-Ping Lin
Journal:  Nat Genet       Date:  2009-10-11       Impact factor: 38.330

8.  Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes.

Authors:  Seyed Ali Mousavi; Faiza Mahmood; Astrid Aandahl; Teresa Risopatron Knutsen; Abid Hussain Llohn
Journal:  Biomed Res Int       Date:  2015-08-26       Impact factor: 3.411

9.  Lessons and Implications from Genome-Wide Association Studies (GWAS) Findings of Blood Cell Phenotypes.

Authors:  Nathalie Chami; Guillaume Lettre
Journal:  Genes (Basel)       Date:  2014-01-27       Impact factor: 4.096

10.  Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans.

Authors:  Stela McLachlan; Claudia Giambartolomei; Jon White; Pimphen Charoen; Andrew Wong; Chris Finan; Jorgen Engmann; Tina Shah; Micha Hersch; Clara Podmore; Alana Cavadino; Barbara J Jefferis; Caroline E Dale; Elina Hypponen; Richard W Morris; Juan P Casas; Meena Kumari; Yoav Ben-Shlomo; Tom R Gaunt; Fotios Drenos; Claudia Langenberg; Diana Kuh; Mika Kivimaki; Rico Rueedi; Gerard Waeber; Aroon D Hingorani; Jacqueline F Price; Ann P Walker
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.